ArticleHeredity2026
First genetic characterization of gastrointestinal nematode communities and benzimidazole resistance in cattle from Argentina.
Article in Heredity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Anthropogenic selective pressures imposed by intensive anthelmintic use provide a powerful framework to investigate rapid evolutionary responses in natural populations. The study described here applied the deep amplicon sequencing of ITS2 rDNA and isotype-1 β-tubulin genes, alongside the Faecal Egg Count Reduction Test, to identify gastrointestinal nematode (GIN) species and assess benzimidazole (BZD) resistance, in six commercial beef cattle farms in Argentina. Seven nematode species were identified, with communities dominated by Haemonchus placei and Cooperia punctata. Screening for isotype-1 β-tubulin (tbb-isotype-1) polymorphisms identified four SNPs known to be associated with BZD resistance: F167Y(TTC>TAC), E198A(GAA>GCA), E198L(GAA>TTG), and F200Y(TTC>TAC), which were identified in C. punctata, Ostertagia ostertagi, H. contortus, and C. oncophora. Treatment failures following BZD administration were mainly associated with C. punctata and, to a lesser extent, O. ostertagi carrying 71.4% of β-tubulin resistance-associated ASVs, consistent with strong directional selection at this locus. Surprisingly, C. punctata survivors frequently carried predominantly susceptible alleles, revealing a marked discordance between genotype and phenotype. In contrast, under combined BZD + macrocyclic lactone treatments, surviving C. punctata predominantly harbored β-tubulin resistance-associated alleles, consistent with enhanced selection under multidrug pressure. Together, these patterns suggest that variation in treatment outcome cannot be fully explained by tbb-isotype-1 alone, and likely involves additional genetic mechanisms, ecological factors such as parasite niche, and/or pharmacokinetic interactions. This study provides the first genetic characterization of GIN communities and BZD resistance in large-scale cattle systems in Argentina, revealing complex resistance dynamics and underscoring the importance of molecular surveillance to guide sustainable parasite control.
Identifiers
42547829What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.